Drug recall · June 2, 2021
Trelegy Ellipta recall
Why: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg; 1 ELLIPTA Inhaler containing 30 doses (60 blisters total) Rx Only NDC 0173-0887-10 GlaxoSmithKline Research Triangle Park, NC 27709
- Lots / codes
3X8P
- Quantity
- 903 inhalers
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- FL, GA, SC
- Initiated
- March 15, 2021 · Voluntary: Firm initiated
- Classified
- May 24, 2021
- Reported
- June 2, 2021
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trelegy
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.